Rosalind Advisors, Inc.
Top Portfolio Positions
32 positions ·
$263,217,963 total
· as of Mar 31, 2026
| Ticker | Company | Shares | Value (USD) | % of Portfolio | Open |
|---|---|---|---|---|---|
| FENC |
Fennec Pharmaceuticals Inc.
Healthcare
|
5,949,734 | $36,590,863 | 13.90% | |
| DCTH |
Delcath Systems, Inc.
Healthcare
|
3,300,389 | $30,627,609 | 11.64% | |
| XERS |
Xeris Biopharma Holdings, Inc.
Healthcare
|
3,231,700 | $18,743,860 | 7.12% | |
| SVRA |
Savara Inc
Healthcare
|
3,203,721 | $17,492,316 | 6.65% | |
| PCVX |
Vaxcyte, Inc.
Healthcare
|
290,000 | $16,851,900 | 6.40% | |
| EYPT |
EyePoint, Inc.
Healthcare
|
1,036,737 | $13,363,539 | 5.08% | |
| XFOR |
X4 Pharmaceuticals, Inc
Healthcare
|
3,214,766 | $13,276,983 | 5.04% | |
| VOR |
Vor Biopharma Inc.
Healthcare
|
700,000 | $12,488,000 | 4.74% | |
| MDWD |
MediWound Ltd.
Healthcare
|
749,054 | $12,067,259 | 4.58% | |
| VSTM |
Verastem, Inc.
Healthcare
|
2,138,475 | $11,333,917 | 4.31% |
Portfolio Trend
10 quarters · across all stocks
Holdings in FENC
Shares Held
Position Value (USD)
8 quarters on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $18,705,427 | 3,041,533 | Shares | Sole | 2026-05-14 | |
| 2026-03-31 | $17,885,436 | 2,908,201 | Shares | Sole | 2026-05-14 | |
| 2025-12-31 | $20,124,011 | 2,613,508 | Shares | Sole | 2026-02-12 | |
| 2025-09-30 | $19,439,222 | 2,076,840 | Shares | Sole | 2025-11-13 | |
| 2025-09-30 | $19,439,222 | 2,076,840 | Shares | Sole | 2025-11-13 | |
| 2025-06-30 | $16,978,845 | 2,045,644 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $10,857,519 | 1,782,844 | Shares | Sole | 2025-05-14 | |
| 2024-12-31 | $7,962,416 | 1,259,876 | Shares | Sole | 2025-02-14 | |
| No 13F history on record for this holder in this stock. | ||||||